Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance

Weixi Feng, Yanli Zhang, Ze Wang, Hanrong Xu, Ting Wu, Charles Marshall, Junying Gao, Ming XiaoAlzheimer 2020 · DOI

Abstract

The glymphatic system and microglial phagocytosis are two primary mechanisms for clearing beta-amyloid (Aβ) from the brain. This study demonstrates that these systems work synergistically to prevent Aβ plaque formation in the early stages of Alzheimer’s disease (AD). When glymphatic clearance is impaired, microglia compensate by increasing Aβ uptake. Protecting or enhancing both pathways may be a viable strategy for delaying AD onset.

Introduction

Alzheimer’s disease (AD) is characterized by the toxic accumulation of beta-amyloid (Aβ) proteins. In a healthy brain, Aβ is cleared via enzymatic degradation, transport across the blood-brain barrier, and the glymphatic system—a macroscopic waste clearance pathway that uses cerebrospinal fluid (CSF) to flush metabolic waste. While these systems are known, their interaction during the early stages of AD remains poorly understood. This paper investigates whether other systems, specifically microglial phagocytosis, can compensate when the glymphatic system fails due to age or injury.

Methods

The researchers utilized a multi-pronged experimental approach using four primary groups of 3-month-old mice: Wild-type (WT), APP/PS1 (AD model), AQP4−/− (impaired glymphatic plumbing), and AQP4−/− / APP/PS1 (AD model with impaired plumbing).

Key methodologies included:

  • Tracer Studies: Fluorescent dyes (TR-d3) were injected into the brain to visualize and quantify glymphatic flow and waste drainage.
  • Genetic Knockouts: AQP4-deficient mice were used to simulate glymphatic failure, as Aquaporin-4 is essential for CSF-interstitial fluid exchange.
  • Microglial Depletion: Clodronate liposomes were used to selectively eliminate microglia to observe their role as a backup clearance system.
  • Gene Silencing: Viral vectors (AAV-siRNA) were employed to knock down Apolipoprotein E (apoE), a protein that influences Aβ aggregation.

Results

Glymphatic Failure and Compensatory Microglial Response

The deletion of AQP4 in AD mice significantly reduced the influx of CSF and the drainage of waste to the deep cervical lymph nodes (dcLNs). Despite this severe impairment, the AQP4−/− / APP/PS1 mice did not develop extracellular plaques at 3 months. Instead, Aβ began to accumulate intraneuronally. This lack of plaques was attributed to a compensatory response by microglia, which became hyper-activated and showed increased expression of phagocytic markers (CD68 and Lamp1).

Figure 5: Visualization and quantification of glymphatic clearance and tracer distribution across mouse models.

The Synergistic Prevention of Plaques

The study established a "two-hit" model for plaque formation. When microglia were eliminated in mice with functional glymphatic systems, plaques did not form at 3 months. However, when microglia were eliminated in AQP4-deficient AD mice, Aβ plaques appeared rapidly. This suggests that extracellular plaques only form when both the primary "plumbing" (glymphatic) and the secondary "janitors" (microglia) fail.

The Role of ApoE

Suppressed glymphatic flow also led to the buildup of apoE. The researchers found that apoE accumulation inhibits Aβ clearance, creating a vicious cycle. Knocking down apoE reduced the amount of Aβ trapped inside neurons, confirming that apoE drainage is a critical component of the glymphatic system's protective role.

Discussion

This research highlights a critical synergy between the glymphatic system and microglia in the early stages of AD. While microglia can initially compensate for glymphatic failure, it is unclear if they can sustain this activity over time or if they eventually reach a state of exhaustion (senescence).

Future work is needed to determine the long-term viability of this microglial compensation and to translate these findings into human therapies. Enhancing AQP4 function or supporting microglial health could provide new avenues for delaying the progression of Alzheimer’s disease.

Summary updated

Abstract

The above results suggest that the glymphatic system mediated Aβ and apoE clearance and microglia mediated Aβ degradation synergistically prevent Aβ plague formation in the early stages of the AD mouse model. Protecting one or both of them might be beneficial to delaying the onset of AD.
BibTeX
@inproceedings{feng2020microglia,
  author = {Weixi Feng and Yanli Zhang and Ze Wang and Hanrong Xu and Ting Wu and Charles Marshall and Junying Gao and Ming Xiao},
  title = {{Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance}},
  booktitle = {Alzheimer},
  year = {2020},
  doi = {10.1186/s13195-020-00688-1},
}
Figure